Abstract:BACKGROUND: It is not known whether rigorous intraoperative glycemic control reduces death and morbidity in cardiac surgery patients.OBJECTIVE: To compare outcomes of intensive insulin therapy during cardiac surgery with those of conventional intraoperative glucose management.DESIGN: A randomized, open-label, controlled trial with blinded end point assessment.SETTING: Tertiary care center.PATIENTS: Adults with and without diabetes who were undergoing on-pump cardiac surgery.MEASUREMENTS: The primary outcome was a composite of death, sternal infections, prolonged ventilation, cardiac arrhythmias, stroke, and renal failure within 30 days after surgery. Secondary outcome measures were length of stay in the intensive care unit and hospital.INTERVENTION: Patients were randomly assigned to receive continuous insulin infusion to maintain intraoperative glucose levels between 4.4 (80 mg/dL) and 5.6 mmol/L (100 mg/dL) (n = 199) or conventional treatment (n = 201). Patients in the conventional treatment group were not given insulin during surgery unless glucose levels were greater than 11.1 mmol/L (>200 mg/dL). Both groups were treated with insulin infusion to maintain normoglycemia after surgery.RESULTS: Mean glucose concentrations were statistically significantly lower in the intensive treatment group at the end of surgery (6.3 mmol/L [SD, 1.6] [114 mg/dL {SD, 29}] in the intensive treatment group vs. 8.7 mmol/L [SD, 2.3] [157 mg/dL {SD, 42}] in the conventional treatment group; difference, -2.4 mmol/L [95% CI, -2.8 to -1.9 mmol/L] [-43 mg/dL {CI, -50 to -35 mg/dL}]). Eighty two of 185 patients (44%) in the intensive treatment group and 86 of 186 patients (46%) in the conventional treatment group had an event (risk ratio, 1.0 [CI, 0.8 to 1.2]). More deaths (4 deaths vs. 0 deaths; P = 0.061) and strokes (8 strokes vs. 1 strokes; P = 0.020) occurred in the intensive treatment group. Length of stay in the intensive care unit (mean, 2 days [SD, 2] vs. 2 days [SD, 3]; difference, 0 days [CI, -1 to 1 days]) and in the hospital (mean, 8 days [SD, 4] vs. 8 days [SD, 5]; difference, 0 days [CI, -1 to 0 days]) was similar for both groups.LIMITATIONS: This single-center study used a composite end point and could not examine whether outcomes differed by diabetes status.CONCLUSIONS: Intensive insulin therapy during cardiac surgery does not reduce perioperative death or morbidity. The increased incidence of death and stroke in the intensive treatment group raises concern about routine implementation of this intervention.

Continuous Blood Glucose Monitoring with Feedback-Controlled Glucose Infusion During Surgical Management of Insulinoma: Report of a Case.

Continuous blood glucose monitoring in insulinoma: report of one case and literature review

Intraoperative intermittently scanned continuous glucose monitoring in the management of patients with pancreatic insulinoma

A Continuous Glucose Monitoring-Fueled Journey

Perioperative Glucose Management for Insulinoma Patients: A Multicenter Retrospective Study of 117 Patients

CGM for Insulinoma Screening: a Prospective and Observational Case-Control Study

Feasibility and Performance of Continuous Glucose Monitoring to Guide Computerized Insulin Infusion Therapy in Cardiovascular Intensive Care Unit

Characteristics and Clinical Significance of Daily Blood Glucose Profiles of Insulinoma Detected by Continuous Glucose Monitoring System

Characteristics of 72 H Glucose Profiles Detected by Continuous Glucose Monitoring System in Patients with Insulinoma

Intraoperative segmental pancreatic occlusion and insulin assay combination optimizes the localization of lesions and confirmation of complete resection in pancreatic hypoglycemia patients

Comparison of a continuous glucose-insulin-potassium infusion versus intermittent bolus application of insulin on perioperative glucose control and hormone status in insulin-treated type 2 diabetics

Impact of Intensive Insulin Therapy on Surgical Critically Ill Patients

Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation

Preliminary Study on Glucose Control with an Artificial Pancreas in Postoperative Sepsis Patients

A Case with Insulinoma Localized by Combined Use of Various Means.

Combining an Electrochemical Continuous Glucose Sensor With an Insulin Delivery Cannula: A Feasibility Study

Diagnosis and Therapy of Insulinomas: Experience in 131 Cases

Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery

[Effect of Intensive Insulin Therapy on the Clinical Results of Postoperative Patients with Gastric Cancer].

The Efficacy of Intraoperatie Continuous Glucose Monitoring in Patients Undergoing Liver Transplantation: a Study Protocol for a Prospective Randomized Controlled Superiority Trial

Automated Insulin Delivery - Continuous Blood Glucose Control During Ex Situ Liver Perfusion